Document Detail


Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.
MedLine Citation:
PMID:  18627293     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bradykinin (BK) coronary outflow and left ventricular (LV) performance of kininogen-deficient Brown Norway Katholiek (BNK) rats and Brown Norway Hannover (BNH) controls were investigated. We analyzed whether the angiotensin-converting enzyme (ACE) inhibitor ramipril is able to attenuate LV dysfunction after induction of myocardial infarction (MI) in this animal model. Ex vivo, the basal BK content in the coronary outflow of buffer-perfused, isolated hearts was measured by specific radioimmunoassay. In vivo, left ventricular pressure (LVP), the maximal rate of LVP increase, LV end-diastolic pressure, the maximal rate of LVP decrease and heart rate were determined using a tip catheter 3 weeks after induction of MI. Compared to BNK rats, basal BK outflow was increased 30-fold in controls (p<0.01). In vivo, we found no significant differences between sham-ligated BNK and BNH rats in basal LV function. After MI, the impairment of LV function was significantly worse in BNK rats when compared to BNH rats. ACE inhibition significantly attenuated this LV dysfunction in both groups, when compared to untreated animals. Reduced basal BK level resulting from kininogen deficiency has no effect on basal LV function, but remains to be a risk factor for the ischemic heart. However, ACE inhibition is sufficient to improve LV function despite kininogen deficiency.
Authors:
Matthias Koch; Klaus Bonaventura; Frank Spillmann; Andreas Dendorfer; Heinz-Peter Schultheiss; Carsten Tschöpe
Related Documents :
1792023 - Effects of hypothyroidism and thyrotoxicosis on metaiodobenzylguanidine kinetics in the...
17006633 - Effects of anesthesia on echocardiographic assessment of left ventricular structure and...
3301363 - Experimental study of argon laser-induced microthrombosis during pgi2 infusion.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biological chemistry     Volume:  389     ISSN:  1431-6730     ISO Abbreviation:  Biol. Chem.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-09-04     Completed Date:  2008-09-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9700112     Medline TA:  Biol Chem     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  719-23     Citation Subset:  IM    
Affiliation:
Department of Cardiology and Pneumology, Charité-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / pharmacology,  therapeutic use*
Animals
Bradykinin / metabolism
Kininogens / deficiency*,  genetics
Male
Mutation
Myocardial Infarction / complications,  metabolism*
Ramipril / pharmacology,  therapeutic use*
Rats
Ventricular Dysfunction, Left / complications,  drug therapy*,  physiopathology*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Kininogens; 58-82-2/Bradykinin; 87333-19-5/Ramipril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gene expression changes associated with the anti-angiogenic activity of kallikrein-related peptidase...
Next Document:  Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia.